HIF-1 in cancer therapy: two decade long story of a transcription factor

References

• Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:47–71.
   PubMed Web of Science ®Google Scholar
• Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352:175–180.
   PubMed Web of Science ®Google Scholar
• Semenza GL, Nejfelt MK, Chi SM, et al. Hypoxia inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA. 1991;88:5680–5684.
   PubMed Web of Science ®Google Scholar
• Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447–5454.
   PubMed Web of Science ®Google Scholar
• Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995;270:1230–1237.
   PubMed Web of Science ®Google Scholar
• Camps C, Saini HK, Mole DR, et al. Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia. Mol Cancer. 2014;13:28–48. doi:10.1186/1476-4598-13-28
   PubMed Web of Science ®Google Scholar
• Kelly BD, Hackett SF, Hirota K, et al. Cell type–specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in non-ischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res. 2003;93:1074–1081.
   PubMed Web of Science ®Google Scholar
• Xia X, Lemieux ME, Li W, et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci USA. 2009;106:4260–4265.
   PubMed Web of Science ®Google Scholar
• Balamurugan K. HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer. 2016;138:1058–1066.
   PubMed Web of Science ®Google Scholar
• Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92:5510–5514.
   PubMed Web of Science ®Google Scholar
• Jiang BH, Rue E, Wang GL, et al. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem. 1996;271:17771–17778.
   PubMed Web of Science ®Google Scholar
• Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 1997;272:22642–22647.
   PubMed Web of Science ®Google Scholar
• Kallio PJ, Okamoto K, O’brien S, et al. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. Embo J.1998;17:6573–6586.
   PubMed Web of Science ®Google Scholar
• Chowdhury R, McDonough MA, Mecinovic J, et al. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure. 2009;17:981–989.
   PubMed Web of Science ®Google Scholar
• Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43–54.
   PubMed Web of Science ®Google Scholar
• Jewell UR, Kveitikova I, Scheid A, et al. Induction of Hif-1alpha in response to hypoxia is instantaneous. FASEB J. 2001;15:1312–1314.
   PubMed Web of Science ®Google Scholar
• Jeong JW, Bae MK, Ahn MY, et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell. 2002;111:709–720.
   PubMed Web of Science ®Google Scholar
• Huang LE, Pete EA, Schau M, et al. Leu-574 of HIF-1alpha is essential for the von Hippel-Lindau (VHL)-mediated degradation pathway . J Biol Chem. 2002;277:41750–41755.
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271–275.
   PubMed Web of Science ®Google Scholar
• McNeill LA, Hewitson KS, Claridge TD, et al. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the β-carbon of asparagine-803. Biochem J. 2002;367:571–575.
   PubMed Web of Science ®Google Scholar
• Dayan F, Roux D, Brahimi-Horn MC, et al. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1α. Cancer Res. 2006;66:3688–3698.
   PubMed Web of Science ®Google Scholar
• Yasinska IM, Sumbayev VV. S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett. 2003;549:105–109.
   PubMed Web of Science ®Google Scholar
• Mazure NM, Brahimi-Horn MC, Berta MA, et al. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol. 2004;68:971–980.
   PubMed Web of Science ®Google Scholar
• Berta MA, Mazure N, Hattab M, et al. SUMOylation of hypoxia-inducible factor-1α reduces its transcriptional activity. Biochem Biophys Res Commun. 2007;360:646–652.
   PubMed Web of Science ®Google Scholar
• Masoud GN, Li W. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 2015;5:378–389.
   PubMed Web of Science ®Google Scholar
• Doonachar A, Gallo MD, Doukas D, et al. Differential effects of HIF-α isoforms on apoptosis in renal carcinoma cell lines. Cancer Cell Int. 2015;15:1.
   PubMed Web of Science ®Google Scholar
• Keith B, Johnson RS, Simon MC. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2011;12:9–22.
   PubMed Web of Science ®Google Scholar
• Holmquist-Mengelbier L, Fredlund E, Lofstedt T, et al. Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype. Cancer Cell. 2006;10:413–423.
   PubMed Web of Science ®Google Scholar
• Torii S, Sakaki K, Otomo M, et al. Nucleocytoplasmic shuttling of IPAS by its unique nuclear import and export signals unshared with other HIF-3α splice variants. J Biochem. 2013;154:561–567.
   PubMed Web of Science ®Google Scholar
• Zhang P, Yao Q, Lu L, et al. Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia. Cell Rep. 2014;6:1110–1121.
   PubMed Web of Science ®Google Scholar
• Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70:1469–1480.
   PubMed Web of Science ®Google Scholar
• Kuschel A, Simon P, Tug S. Functional regulation of HIF‐1α under normoxia-is there more than post‐translational regulation? J Cell Physiol. 2012;227:514–524.
   PubMed Web of Science ®Google Scholar
• Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing . Science. 2001;292:464–468.
   PubMed Web of Science ®Google Scholar
• Sun Q, Chen X, Ma J, et al. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type m2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci USA. 2011;108:4129–4134.
   PubMed Web of Science ®Google Scholar
• Agani F, Jiang BH. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Curr Cancer Drug Targets. 2013;13:245–251.
   PubMed Web of Science ®Google Scholar
• Carrera S, Senra J, Acosta MI, et al. The role of the HIF-1α transcription factor in increased cell division at physiological oxygen tensions. PLoS One. 2014;9:e97938.
   PubMed Web of Science ®Google Scholar
• Lau CK, Yang ZF, Ho DW, et al. An Akt/hypoxia-inducible factor-1α/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin Cancer Res. 2009;15:3462–3471.
   PubMed Web of Science ®Google Scholar
• Biswas S, Mukherjee R, Tapryal N, et al. Insulin regulates hypoxia-inducible factor-1α transcription by reactive oxygen species sensitive activation of Sp1 in 3T3-L1 preadipocyte. PLoS One. 2013;8:e62128.
   PubMed Web of Science ®Google Scholar
• Sinha S, Koul N, Dixit D, et al. IGF-1 induced HIF-1α-TLR9 cross talk regulates inflammatory responses in glioma. Cell Signal. 2011;23:1869–1875.
   PubMed Web of Science ®Google Scholar
• Yoon H, Shin SH, Shin DH, et al. Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses. Biochem Biophys Res Commun. 2014;444:36–43.
   PubMed Web of Science ®Google Scholar
• Elser M, Borsig L, Hassa PO, et al. Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression. Mol Cancer Res. 2008;6:282–290.
   PubMed Web of Science ®Google Scholar
• Quintero M, Brennan PA, Thomas GJ, et al. Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation. Cancer Res. 2006;66:770–774.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Mayer A. Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications. Adv Exp Med Biol. 2014;812:19–24.
   PubMed Web of Science ®Google Scholar
• Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005;105:659–669.
   PubMed Web of Science ®Google Scholar
• Huang Z, Xu R, Lv C, et al. A chronic obstructive pulmonary disease negatively influences the prognosis of patients with bladder urothelial carcinoma via hypoxia inducible factor-1alpha. Int J Clin Exp Med. 2014;7:3344–3353.
   PubMed Web of Science ®Google Scholar
• Maroni P, Matteucci E, Drago L, et al. Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma. Exp Cell Res. 2015;330:287–299.
   PubMed Web of Science ®Google Scholar
• Haugland HK, Vukovic V, Pintilie M, et al. Expression of hypoxia-inducible factor-1α in cervical carcinomas: correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys. 2002;53:854–861.
   PubMed Web of Science ®Google Scholar
• Jo JO, Kim SR, Bae MK, et al. Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1α-dependent manner. BBA-Mol Cell Res. 2010;1803:1244–1251.
   PubMed Web of Science ®Google Scholar
• Malfettone A, Silvestris N, Paradiso A, et al. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. Exp Mol Pathol. 2012;92:296–303.
   PubMed Web of Science ®Google Scholar
• Horree N, Gort EH, Van der Groep P, et al. Hypoxia‐inducible factor 1α is essential for hypoxic p27 induction in endometrioid endometrial carcinoma. J Pathol. 2008;214:38–45.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lu Y, Lu C, et al. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1α expression. Pathol Oncol Res. 2009;15:487–493.
   PubMed Web of Science ®Google Scholar
• Takahashi R, Tanaka S, Hiyama T, et al. Hypoxia-inducible factor 1α expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep. 2003;10:797–802.
   PubMed Web of Science ®Google Scholar
• Hermansen SK, Nielsen BS, Aaberg-Jessen C, et al. miR-21 is linked to glioma angiogenesis-a co-localization study. J Histochem Cytochem. 2016;64:138–148.
   PubMed Web of Science ®Google Scholar
• Jokilehto T, Rantanen K, Luukkaa M, et al. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Clin Cancer Res. 2006;12:1080–1087.
   PubMed Web of Science ®Google Scholar
• Wu XH, Lu YF, Hu XD, et al. Expression of hypoxia inducible factor-1α and its significance in laryngeal carcinoma. J Int Med Res. 2010;38:2040–2046.
   PubMed Web of Science ®Google Scholar
• Yasuda S, Arii S, Mori A, et al. Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. J Hepatol. 2004;40:117–123.
   PubMed Web of Science ®Google Scholar
• Aquino-Galvez A, Gonzalez-Avila G, Delgado-Tello J, et al. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia. Oncol Rep. 2016;35:577–583.
   PubMed Web of Science ®Google Scholar
• Slominski A, Kim TK, Brozyna AA, et al. The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways. Arch Biochem Biophys. 2014;563:79–93.
   PubMed Web of Science ®Google Scholar
• Abraham S, Hu N, Jensen R. Hypoxia-inducible factor-1-regulated protein expression and oligodendroglioma patient outcome: comparison with established biomarkers and preoperative UCSF low-grade scoring system. J Neurooncol. 2012;108:459–468.
   PubMed Web of Science ®Google Scholar
• Zhou ZL, Luo ZG, Yu B, et al. Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide. Mol Cancer. 2010;9:268–278.
   PubMed Web of Science ®Google Scholar
• Zapatero A, Morente M, de Vidales CM, et al. HIF1A expression in localized prostate cancer treated with dose escalation radiation therapy. Cancer Biomark. 2015;15:41–46.
   PubMed Web of Science ®Google Scholar
• Klatte T, Seligson DB, Riggs SB, et al. Hypoxia-inducible factor 1α in clear cell renal cell carcinoma. Clin Cancer Res. 2007;13:7388–7393.
   PubMed Web of Science ®Google Scholar
• Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the Use of 18F-FDG PET in Oncology. J Nucl Med. 2008;49:480–508.
   PubMed Web of Science ®Google Scholar
• Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496:238–242.
   PubMed Web of Science ®Google Scholar
• Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ, et al. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. MRMC. 2009;9:1084–1101.
   Web of Science ®Google Scholar
• Luo W, Semenza GL. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget. 2011;2:551–556.
   PubMed Web of Science ®Google Scholar
• Parks SK, Chiche J, Pouyssegur J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer. 2013;13:611–623.
   PubMed Web of Science ®Google Scholar
• He GD, Jiang Y, Zhang B, et al. The effect of HIF-1α on glucose metabolism, growth and apoptosis of pancreatic cancerous cells. Asia Pac J Clin Nutr. 2014;23:174–180.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol. 2011;76:347–353.
   PubMedGoogle Scholar
• Dang CV, Kim JW, Gao P, et al. The interplay between MYC and HIF in cancer. Nat Rev Cancer. 2008;8:51–56.
   PubMed Web of Science ®Google Scholar
• Fukuda R, Zhang H, Kim JW, et al. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell. 2007;129:111–122.
   PubMed Web of Science ®Google Scholar
• Walls KC, Ghosh AP, Ballestas ME, et al. bcl-2/Adenovirus E1B 19-kd interacting protein 3 (BNIP3) regulates hypoxia-induced neural precursor cell death. J Neuropathol Exp Neurol. 2009;68:1326–1338.
   PubMed Web of Science ®Google Scholar
• Ranjan K, Pathak C. Expression of cFLIPL Determines the Basal Interaction of Bcl‐2 With Beclin‐1 and Regulates p53 Dependent Ubiquitination of Beclin‐1 During Autophagic Stress. J Cell Biochem. 2016;117:1757–1768.
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu J, Wu R, et al. Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD. Oncotarget. 2014;5:5535–5546.
   PubMed Web of Science ®Google Scholar
• Morfoisse F, Kuchnio A, Frainay C, et al. Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1α-independent translation-mediated mechanism. Cell Rep. 2014;6:155–167.
   PubMed Web of Science ®Google Scholar
• Rigiracciolo DC, Scarpelli A, Lappano R, et al. Copper activates HIF-1α/GPER/VEGF signalling in cancer cells. Oncotarget. 2015;6:34158–34177.
   PubMed Web of Science ®Google Scholar
• Azoitei N, Becher A, Steinestel K, et al. PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation. Mol Cancer. 2016;15:3–17.
   PubMed Web of Science ®Google Scholar
• Rey S, Semenza GL. Hypoxia-inducible factor-1- dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res. 2010;86:236–242.
   PubMed Web of Science ®Google Scholar
• Lee K, Zhang H, Qian DZ, et al. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc Natl Acad Sci USA. 2009;106:17910–17915.
   PubMed Web of Science ®Google Scholar
• Greco S, Martelli F. MicroRNAs in Hypoxia Response. Antioxid Redox Signal. 2014;21:1164–1166.
   PubMed Web of Science ®Google Scholar
• Bartoszewska S, Kochan K, Piotrowski A, et al. The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1α expression in human endothelial cells through a negative feedback loop. Faseb J. 2015;29:1467–1479.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhou X, Wang B, et al. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma. Oral Oncol. 2014;50:809–817.
   PubMed Web of Science ®Google Scholar
• Krishnamachary B, Zagzag D, Nagasawa H, et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. 2006;66:2725–2731.
   PubMed Web of Science ®Google Scholar
• Wong CC, Gilkes DM, Zhang H, et al. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc Natl Acad Sci USA. 2011;108:16369–16374.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wong CC, Wei H, et al. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene. 2012;31:1757–1770.
   PubMed Web of Science ®Google Scholar
• Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer. 2009;9:285–293.
   PubMed Web of Science ®Google Scholar
• Oskarsson T, Batlle E, Massague J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014;14:306–321.
   PubMed Web of Science ®Google Scholar
• Peng G, Liu Y. Hypoxia-inducible factors in cancer stem cells and inflammation. Trends Pharmacol Sci. 2015;36:374–383.
   PubMed Web of Science ®Google Scholar
• Conley SJ, Gheordunescu E, Kakarala P, et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci USA. 2012;109:2784–2789.
   PubMed Web of Science ®Google Scholar
• Samanta D, Gilkes DM, Chaturvedi P, et al. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc Natl Acad Sci USA. 2014;111:5429–5438.
   PubMed Web of Science ®Google Scholar
• Barak V, Pe’er J, Kalickman I, et al. VEGF as a biomarker for metastatic uveal melanoma in humans. Curr Eye Res. 2011;36:386–390.
   PubMed Web of Science ®Google Scholar
• Kumar H, Choi DK. Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway? Mediators Inflamm. 2015;2015:584758.
   PubMed Web of Science ®Google Scholar
• Santore MT, McClintock DS, Lee VY, et al. Anoxia-induced apoptosis occurs through a mitochondria-dependent pathway in lung epithelial cells. Am J Physiol Lung Cell Mol. Physiol. 2002;282:L727–L734.
   PubMed Web of Science ®Google Scholar
• McClintock DS, Santore MT, Lee VY, et al. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol. 2002;22:94–104.
   PubMed Web of Science ®Google Scholar
• Yoo BH, Wu X, Derouet M, et al. Hypoxia-induced downregulation of autophagy mediator Beclin 1 reduces the susceptibility of malignant intestinal epithelial cells to hypoxia-dependent apoptosis. Autophagy. 2009;5:1166–1179.
   PubMed Web of Science ®Google Scholar
• Li F, Chen X, Xu B, et al. Curcumin induces p53-independent necrosis in H1299 cells via a mitochondria-associated pathway. Mol Med Rep. 2015;12:7806–7814.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012;33:207–214.
   PubMed Web of Science ®Google Scholar
• Sermeus A, Michiels C. Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis. 2011;2:e164.
   PubMed Web of Science ®Google Scholar
• Muh CR, Joshi S, Singh AR, et al. PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression. J Neurooncol. 2014;116:89–97.
   PubMed Web of Science ®Google Scholar
• Kamat CD, Green DE, Warnke L, et al. Mutant p53 facilitates pro-angiogenic, hyperproliferative phenotype in response to chronic relative hypoxia. Cancer Lett. 2007;249:209–219.
   PubMed Web of Science ®Google Scholar
• Katschinski DM, Le L, Schindler SG, et al. Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1α stabilization. Cell Physiol Biochem. 2004;14:351–360.
   PubMed Web of Science ®Google Scholar
• Faubert B, Vincent EE, Griss T, et al. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α. Proc Natl Acad Sci USA. 2014;111:2554–2559.
   PubMed Web of Science ®Google Scholar
• Pan JG, Mak TW. Metabolic targeting as an anticancer strategy: dawn of a new era? Sci STKE. 2007;381:e14.
   Google Scholar
• Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med. 2011;365:537–547.
   PubMed Web of Science ®Google Scholar
• Velasco-Hernandez T, Hyrenius-Wittsten A, Rehn M, et al. HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia. Blood. 2014;124:3597–3607.
   PubMed Web of Science ®Google Scholar
• Maranchie JK, Vasselli JR, Riss J, et al. The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell. 2002;1:247–255.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li H, Xi HS, et al. HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells. Blood. 2012;119:2595–2607.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Y, Malek SN, et al. Targeting HIF1α eliminates cancer stem cells in hematological malignancies. Cell Stem Cell. 2011;8:399–411.
   PubMed Web of Science ®Google Scholar
• Näthke I, Rocha S. Antagonistic crosstalk between APC and HIF-1α. Cell Cycle. 2011;10:1545–1547.
   PubMed Web of Science ®Google Scholar
• Kumar S, Vaidya M. Hypoxia inhibits mesenchymal stem cell proliferation through HIF1α-dependent regulation of P27. Mol Cell Biochem. 2016;415:29–38.
   PubMed Web of Science ®Google Scholar
• Cai Z, Luo W, Zhan H, et al. Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc Natl Acad Sci USA. 2013;110:17462–17467.
   PubMed Web of Science ®Google Scholar
• Karuppagounder SS, Ratan RR. Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics? J Cereb Blood Flow Metab. 2012;32:1347–1361.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shao Z, Zhai Z, et al. The HIF-1 hypoxia-inducible factor modulates lifespan in C. elegans. PLoS One. 2009;4:6348–6356.
   PubMed Web of Science ®Google Scholar
• Wigerup C, Påhlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther. 2016;164:152–169.
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu J, Huang H. Recent agents targeting HIF‐1α for cancer therapy. J Cell Biochem. 2013;114:498–509.
   PubMed Web of Science ®Google Scholar
• Falchook GS, Wheler JJ, Naing A, et al. Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. Oncotarget. 2014;5:10280–10292.
   PubMed Web of Science ®Google Scholar
• Ban HS, Uto Y, Won M, et al. ( 2016;). Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015). Expert Opin Ther Pat. 26:309–322.
   PubMed Web of Science ®Google Scholar
• Shay JE, Imtiyaz HZ, Sivanand S, et al. Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer. Carcinogenesis. 2014;35:1067–1077.
   PubMed Web of Science ®Google Scholar
• Zhong H, D, Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999;59:5830–5835.
   PubMed Web of Science ®Google Scholar